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Abstract
Assembly and release of human immunodeficiency virus (HIV) occur at the plasma membrane of infected cells and are
driven by the Gag polyprotein. Previous studies analyzed viral morphogenesis using biochemical methods and static
images, while dynamic and kinetic information has been lacking until very recently. Using a combination of wide-field and
total internal reflection fluorescence microscopy, we have investigated the assembly and release of fluorescently labeled
HIV-1 at the plasma membrane of living cells with high time resolution. Gag assembled into discrete clusters corresponding
to single virions. Formation of multiple particles from the same site was rarely observed. Using a photoconvertible
fluorescent protein fused to Gag, we determined that assembly was nucleated preferentially by Gag molecules that had
recently attached to the plasma membrane or arrived directly from the cytosol. Both membrane-bound and cytosol derived
Gag polyproteins contributed to the growing bud. After their initial appearance, assembly sites accumulated at the plasma
membrane of individual cells over 1–2 hours. Assembly kinetics were rapid: the number of Gag molecules at a budding site
increased, following a saturating exponential with a rate constant of ,5610
23 s
21, corresponding to 8–9 min for 90%
completion of assembly for a single virion. Release of extracellular particles was observed at ,1,5006700 s after the onset
of assembly. The ability of the virus to recruit components of the cellular ESCRT machinery or to undergo proteolytic
maturation, or the absence of Vpu did not significantly alter the assembly kinetics.
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Introduction
Assembly and release of progeny virions are fundamental steps
in viral replication. In the case of retroviruses, such as human
immunodeficiency virus type 1 (HIV-1), the viral structural
polyprotein Gag plays a central role in mediating both of these
processes which occur concomitantly at the plasma membrane of
the infected cell. Gag comprises domains required for membrane
binding, multimerization, nucleic acid binding as well as for
interaction with the host cell derived budding machinery and has
been demonstrated to direct the formation of virus like particles
(VLP) in the absence of other viral proteins [1]. During or shortly
after virus release, Gag is cleaved by the viral protease resulting in
domain separation and maturation of the infectious virion (for
review see [2,3,4]).
The assembly process, leading from monomeric Gag molecules
translated at cytoplasmic polysomes to the virus bud comprising
several thousand Gag molecules at the plasma membrane, has
been investigated using a variety of techniques. Results from pulse-
chase labeling, density gradient fractionation, time-lapse fluores-
cence imaging and intracellular fluorescence resonance energy
transfer measurements have resulted in a current general view of
retroviral assembly: Gag is rapidly converted from a soluble form
to a multimeric, membrane associated complex and this process is
reflected by changes in the distribution of Gag within the cell (e.g.
[5,6,7,8,9,10]). Initial Gag-Gag interactions occur prior to arrival
at the plasma membrane, while assembly of higher order
structures appears to be confined to the plasma membrane. At
the membrane, Gag localizes to or induces membrane micro-
domains from which budding and release are believed to occur
(e.g. [11,12,13,14]). All these steps may be influenced by cellular
factors, but these factors and their mechanistic role are currently
poorly understood (reviewed in [2,15]). Completion of budding
and release require the cellular ESCRT machinery, normally
involved in endosomal sorting and cytokinesis (reviewed in
[16,17,18]).
While the general pathway of HIV morphogenesis has been
elucidated in recent years, several aspects are still controversial and
the details of this process and in particular its kinetics are poorly
understood. Oligo- or multimers of Gag have been detected in the
cytoplasm and at intracellular membranes [10,19] and are
believed to be assembly intermediates, but the size of Gag
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are currently not known. It is also unclear, whether Gag molecules
are recruited from the cytoplasm or an intracellular membrane to
the budding site or whether they first associate with the plasma
membrane and are then organized into a budding structure by
lateral movement. Budding may occur from platforms giving rise
to multiple consecutive budding events, as has been reported for
Rous sarcoma virus [20], or may occur mostly from unique sites,
as suggested for Moloney murine leukemia virus [21]. Finally, the
kinetics of assembly have only recently been described [22] and
kinetics of release are unknown at present. While traditional
biochemical and cell biology techniques are not well suited to
address these aspects, insight can be gained from direct
visualization of budding site formation at the plasma membrane
with high time resolution. Such studies are now possible due to
recent advances in technology. Gladnikoff et al. applied atomic
force microscopy to monitor retroviral budding [21], albeit with a
technically limited time resolution of several minutes per frame.
Atomic force microscopy is only suited for the analysis of budding,
however, since it measures distortion of the membrane, while
analysis of the initial nucleation complex and early assembly
requires other techniques.
To investigate the kinetics of HIV assembly at high time
resolution, we employed a combination of wide-field (WF) and
total internal reflection fluorescence (TIRF) microscopy in
conjunction with fluorescently labeled and photoconvertible
HIV-1 derivatives. Jouvenet et al. also analyzed the dynamics of
VLP formation by fluorescently labeled Gag polyproteins and
reported assembly of Gag complexes to occur within minutes [22].
Here, we confirm and extend this analysis by investigating the
dynamics of HIV-1 assembly in more detail, using a complete viral
plasmid expressing all HIV-1 proteins except Nef and determining
the time until a complete virion is released. Virions assembled at
individual sites and rarely appeared to bud from larger Gag
platforms. The rate of assembly was similar for wild-type HIV and
for variants that lack the PTAP late domain motif or are deficient
in protease activity. Using a recently developed photoconvertible
protein, it was found that nucleation of the assembly site and bud
growth occurred preferentially from cytosolic Gag molecules. The
average time from the appearance of an assembly site at the
plasma membrane to release was 1,5006700 seconds.
Results/Discussion
Rapid accumulation of HIV-1 assembly sites after initial
nucleation
The HIV-1 Gag protein is the main driving force for virion
assembly and Gag by itself can assemble into virus-like particles
which are released from expressing cells [1]. However, the details
of the assembly and release processes may be influenced by other
virus components. Furthermore, it has been demonstrated that the
steps of Gag targeting and release may be influenced by the
nuclear export pathway of its encoding mRNA, which in the case
of HIV is mediated by the virus encoded protein Rev [23]. For this
reason, we believe that Gag analyzed in a viral context will most
accurately reflect the kinetics of HIV-1 assembly and release in
living cells. Thus, we made use of a fluorescently labeled HIV-1
derivative with the egfp gene inserted between the MA and CA
coding regions of the gag gene. Cells transfected with an equimolar
mixture of this construct and its wild-type (wt) counterpart
produce highly fluorescent particles displaying wt morphology
and infectivity [24]. For the microscopic analyses described here,
non-infectious derivatives lacking the long terminal repeat regions
[25] were used. These constructs express Gag in the viral context,
i.e. in the presence of all other HIV proteins (except for Nef) and
dependent on Rev mediated nuclear export of the encoding RNA.
For these reasons, Gag accumulation is slower and overall Gag
expression levels are much lower than for the Rev-independent,
codon-optimized version of Gag alone used in a previous study
[22]. For our studies, time points between 20 and 30 h post
transfection (hpt) were found to be optimal for microscopic
observation of budding site formation in HeLa cells.
Jouvenet et al. have demonstrated the capability of investigating
the assembly of HIV-1 with TIRFM [22]. In order to gain
quantitative information over the assembly process, it is necessary
to distinguish between changes in the fluorescence intensity arising
from the incorporation of new fluorescently labeled Gag particles
and axial movements of the complex in the exponentially decaying
evanescent field of the TIRF microscope [26]. To this end, we
have constructed a custom-made microscope capable of switching
between TIRF and WF microscopy modes in alternating frames
up to frame rates of 30 Hz. A diagram of the experimental setup is
shown in Figure S1 and details can be found in the materials and
methods and supporting information. Figure 1A and B shows a
cell producing fluorescent HIV-1 imaged by WF and TIRF
microscopy, respectively. Individual punctate clusters of Ga-
g.eGFP were detected and tracked in TIRF mode and the
corresponding fluorescence of the punctae in WF was determined.
As can be seen in Video S1, the fluorescent punctae were typically
mobile. In order to perform a quantitative, statistically meaningful
analysis, software was developed to semi-automatically track large
numbers of individual punctae in up to three different color
channels or different microscopy modes. The background-
corrected intensity, particle location, and instantaneous velocities
of the individual assembly complexes were calculated and
analyzed (see also SI and ref [27]).
In the time window of 20–30 hpt chosen for our analysis, the
extent of Gag expression varied strongly from cell to cell. Some
cells were already displaying bright fluorescence at 20 hpt while
others showed detectable fluorescent Gag expression only towards
the end of the observation period. The appearance of Gag punctae
in our system did not correlate with the level of Gag expression in
contrast to the results obtained for Gag.GFP in the previous study
Author Summary
Human immunodeficiency virus (HIV) particles are formed
and released at the plasma membrane of the infected cell.
Here, we analyzed the dynamics of HIV assembly and
release making use of fluorescently labeled HIV structural
proteins. We determined that assembly of the viral protein
shell occurs within ,8–9 min after nucleation of an
assembly site and virus particles are formed individually
and not from large patches. Virion release was observed
,25 min after nucleation of the assembly site. Assembly of
the Gag shell thus appears to constitute only a minor part
of the period required for particle formation indicating
that traversing the membrane and fission are the rate-
limiting stages in virion formation. Using a photoconver-
tible label in the viral Gag protein, we established that the
Gag molecules driving nucleation of a new assembly site
and in bud growth are recruited preferentially from the
cytosolic pool of Gag molecules and from recently
membrane-attached Gag. No intracellular assembly or
vesicular trafficking of Gag was observed. The described
results add essential dynamic information to our picture of
virus release and provide an experimental basis for
interfering with this stage of virus replication.
HIV Budding
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assembly of Gag complexes with time. This difference may be due
to the faster and higher expression of this codon-optimized Gag
encoding construct used in the previous study and possibly also to
its Rev-independence. Some cells exhibited bright cytosolic
fluorescence over several hours without showing formation of
punctate clusters. Hence, we selected cells where the first punctae
at the plasma membrane became detectable at the beginning of
the observation period and measured the dynamics of assembly
and budding over 1 to 2 hours with a temporal resolution of 2 s/
frame. Punctate clusters rapidly accumulated at the plasma
membrane within approximately one hour after the initial
detection of individual nucleation sites (Figure S2). At later time
points, the cell membrane became densely packed with punctate
clusters, which made tracking of individual clusters problematic.
Cotransfection of constructs expressing Gag.mCherry and the
early endosome marker GFP.Rab5 revealed no colocalization of
Gag.mCherry punctae with early endosomes during our observa-
tion window (data not shown). This is consistent with the fact that
the constructs used express the viral protein Vpu, which is able to
counteract attachment and endocytosis of newly produced virions
proposed to be mediated by cellular restriction factors in HeLa
cells [28,29,30].
Assembly sites correspond to single nascent virions
To determine whether the observed punctae represent individ-
ual nascent virions or larger accumulations of Gag molecules
serving as budding platforms, we estimated the overall size of
Gag.eGFP punctae from their relative fluorescence intensity. The
fluorescence intensity distribution of punctate assembly sites was
compared to that of particles released during the live-cell imaging
experiments, which were found attached to the cover slip between
HIV-1 producing cells, as well as to individual particles from a
purified HIV
eGFP preparation (Figure 1C). We have previously
established that purified HIV
eGFP preparations consist of a single
particle population with an average diameter of 172610 nm and
do not contain large aggregates [31]. However, the fluorescence
intensities of individual particles are broadly distributed corre-
sponding to the variability of particle diameters and total number
of Gag molecules per virion [32,33]. Recent results further suggest
that Gag stoichiometry also varies with the amount of Gag
produced per cell [33]. Furthermore, the co-expression system
used in this study can result in variations in the ratio of labelled to
unlabelled Gag between different cells. Accordingly, differences in
average particle intensities between individual cells as well as
between experiments were observed. However, the fluorescence
intensity of membrane associated Gag clusters was consistently less
than or similar to that of free particles bound to the coverslip
during the course of the imaging experiment or of particles
purified from the supernatant of virus producing cells (Figure 1C).
This suggests that the Gag.eGFP assemblies in the stationary
phase (phase II discussed in the next section) contain roughly the
same amount of Gag as individual released particles and do not
represent larger assembly patches but rather individual virus buds.
This conclusion is supported by the observation that appearance
of multiple particles from the same site was very rare. Video S2
demonstrates the one instance in several hundred events analyzed
where multiple particles appeared to bud from a single site. Similar
results have been reported for Rous sarcoma virus using two-
photon live-cell imaging [20] and for Moloney murine leukemia
virus using atomic force microscopy [21]. Recently, Manley et al.
measured the movement of HIV-1 Gag fused to a tandem dimer
of EosFP using photoactivated localization microscopy [34] and
reported that immobile Gag molecules were often found in clusters
with a radius of less than 300 nm, which also argues against the
formation of large Gag assemblies serving as budding platforms.
Kinetics of virus assembly
Having established that Gag clusters correspond to individual
assembly sites, we investigated the kinetics of the assembly process.
Figure 2A and B display the appearance of two individual
fluorescent clusters (indicated by arrows in Figure 1A and B) of
Gag.eGFP above the cytosolic background. Fluorescence intensi-
ties of individual clusters were found to change in three
characteristic phases. Formation of the budding site was observed
as a rapid increase in fluorescence intensity during the first few
minutes after initial detection (Phase I), followed by a stationary
phase where the fluorescence signal fluctuates about a constant
value (Phase II). The duration of this plateau phase varied between
individual clusters. Subsequently, a decay of fluorescence intensity
was observed (Phase III).
Figure 1. Live cell imaging of individual HIV-1 assembly sites.
HeLa cell transfected with a mixture of pCHIV and pCHIV
eGFP imaged at
25 h hpt (A) in WF and (B) in TIRF mode. The scale bar represents 5 mm.
The arrow and the arrow head indicate the two individual punctae
analyzed in Figure 2A and B respectively. (C), Normalized histograms of
fluorescence intensities from Gag punctae on the cell surface (upper
panel, shown in hatched bars with different colors representing
different cells) and released particles that adhered to the coverslip
after cell retraction during a live-cell imaging experiment (lower panel,
hatched bars). For comparison, the fluorescence intensity distribution of
a purified particle preparation is shown in grey bars in both panels (the
normalized area of the histogram has been scaled by a factor of 2 for
clarity).
doi:10.1371/journal.ppat.1000652.g001
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saturating exponential (in ,80% of all cases), a linear increase in
intensity until saturation was reached (10–20%) or intensities that
increased exponentially until reaching a plateau (,3%) (Figure
S3). Here, we concentrate on the most prevalent behavior, the
saturating exponential. To determine the kinetics of assembly, we
averaged 309 individual traces with a minimal length of 300
frames, corresponding to 10 min (Figure 3A). The asynchronous
initiation of assembly sites was compensated for by aligning the
intensity traces before averaging. Details of the averaging process
are given in the Supporting Text S1. The average value (black
line) and the standard deviation (light grey halo) of the selected
traces are plotted for measurements on single cells. In contrast to
Jouvenet et al. [22], who measured the time between the onset of
assembly and saturation, we describe the budding kinetics in terms
of a model function. The red line displays the fit of the data to a
saturating exponential function,
y~AI 1{exp {kI t{t0 ðÞ ½  ðÞ , ð1Þ
where AI is the maximum fluorescence amplitude, kI is the rate of
fluorescence increase and t0 is the time when assembly begins. By
averaging and fitting the kinetics to a model function, our
estimation of the assembly rate is independent of uncertainties in
detection of the particle at early time points and in the subjective
determination of when assembly is complete. The values derived
from experiments on multiple cells are summarized in Table 1.
The rate of assembly is ,4.3610
23 s
21 or 233 s, which
corresponds to a time of ,9 minutes for 90% completion of
assembly. To determine the distribution of assembly rates for
individual sites, single traces were fit separately to equation (1).
The resulting histogram (Figure 4C, left panel) could be
approximated by a log-normal distribution of rates. The
maximum position of (5.560.5)610
23 s
21 obtained from this
distribution corresponds well to the rate of 4.3610
23 s
21
determined from the averaged traces shown in Figure 3A.
We confirmed the observed assembly rates using SDCM (Video
S3). While SDCM does not offer the contrast of TIRF microscopy,
it has the advantage that three-dimensional information is
collected and a projection of the z-stack can then be used for
tracking of the individual assembly sites. Hence, the measured
fluorescence intensity is not sensitive to axial motion of a cluster
over several micrometers. The SDCM measurements confirmed
the saturating exponential kinetics of Phase I yielding comparable
rates (kI=5.5610
23 s
21 for the ensemble average in Figure S4
and kI=3.6610
23 s
21 for the typical trace shown in Figure S4A).
Figure 2. The three phases of HIV-1 assembly. (A–B) Intensity traces of two individual Gag.eGFP clusters indicated with an arrow (A) and arrow
head (B) in Figure 1 recorded in TIRF (black line) and WF (grey line) modes are shown in the top panels. Three phases, separated here by dashed lines,
can be observed: Phase I) a rapid rise in fluorescence intensity, Phase II) a plateau region with fluctuations in fluorescence intensity, and Phase III) a
decay of the fluorescence signal. The middle panels show the intensity traces of the local background. The bottom panel displays a plot of the
corresponding instantaneous velocities of the particles. In A, an abrupt increase in instantaneous velocity is observed concomitantly with the onset of
Phase III. (C) Trajectory of the individual Gag.eGFP cluster from panel A color-coded according to the three different phases. The scale bar represents
1 mm. (D) A mean-square displacement analysis of the trajectory shown in panel C indicates the random character of motion in the different phases
and shows a change by two orders of magnitude in diffusion coefficient between the phases I+II and III.
doi:10.1371/journal.ppat.1000652.g002
HIV Budding
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completion of assembly) is in a similar range with the estimate of
5–6 minutes for complete assembly made by Jouvenet et al [22].
The variation of rates between individual sites on one cell
suggests that additional factors besides the overall Gag concen-
tration influence the rate of assembly. We analyzed the rate of
HIV assembly at early (0–25 minutes) and intermediate (40–
60 minutes) time points of Video S1. Between these time intervals,
the concentration of Gag at the plasma membrane increased
significantly whereas the concentration of Gag in the cytosol
remained relatively constant. The assembly rates for the two time
periods were similar (compare Figure 4A and 4B). Moreover, we
observed no change in the assembly rates of individual assembly
sites as a function of time after onset of punctae formation
(Figure 4C). Considering that some cells exhibited cytosolic
fluorescence for hours without producing virus particles and that
the rate of assembly appear to be independent of Gag
concentration one can speculate that additional factors are
involved in the initiation of assembly with some cells apparently
lacking assembly competence.
The observed saturating exponential increase in fluorescence
intensity indicates that Gag accumulation at a growing budding site
is retarded over time and eventually stops. The simplest explanation
for this observation is that completion of the spherical Gag shell is
preventing the addition of further Gag molecules. However, this is
inconsistent with data from electron cryo-tomography experiments
showing that the Gag shell of immature particles is incomplete
[35,36]. Therefore, other mechanisms must be responsible for
restricting Gag incorporation, such as Gag-induced membrane
curvature or closure of the bud neck by the cellular ESCRT
machinery restricting access for further Gag molecules.
After the initial increase in fluorescence intensity (phase I), the
signal fluctuated about a nearly constant average intensity for
variable time periods (Phase II) before a decay in fluorescence
intensity was observed (phase III). Using photobleaching experi-
ments, Jouvenet et al. [22] have shown that there is no exchange of
Gag between the assembly site and the cellular environment during
the plateau region following the assembly phase. This phase most
likely reflects the interaction of the assembled Gag shell with cellular
membrane constituents but further investigations are required to
elucidate the biological significance of phase II. We determined the
duration of phases I+II, i.e. the time period between the first
detection of the assembly site and the onset of phase III, for 160
individual trajectories (Figure S5A). The total duration of phase I+II
is 1,3006700 s. Using 90% saturation of phase I (90% level of the
exponential amplitude in equation (1)) as the onset of the phase II,
the average duration of phase II was determined to be ,10 min.
The duration of phase II varied between individual events and the
distribution is shown in Figure S5B.
Phase III is defined by a decay in fluorescence intensity of the
TIRF signal. It began abruptly as seen in Figure 2A and 2B,
indicating a change in particle behavior. This phase was also
frequently observed in wide-field mode. We characterized the
dynamics of phase III by averaging multiple traces as we did to
analyze phase I (see Supporting Text S1). The results were fit to a
decaying exponential function with an offset:
y~AIII exp {kIII t{t0 ðÞ ðÞ zBIII : ð2Þ
The results are given in Table 1. A rate of 2.7610
23 s
21 was
determined for phase III. Many physical processes can potentially
contribute to the decay of fluorescence intensity. These processes
include (i) loss of Gag.eGFP molecules from the assembly site, (ii) a
change in the distance of the particle from the cover slip or (iii)
increased motility of the particle upon budding or dissociation from
cellular factors. Most likely, multiple factors are responsible for the
fluorescence decay in phase III and their contribution may vary from
event to event. For example, formation of the budding structure may
cause Gag molecules to approach the coverslip. This would lead to
higher illumination intensities and faster photobleaching rates. Hence,
Figure 3. Average kinetics of phases I and III. The rates of
processes involved in HIV
eGFP assembly determined from single cells
using TIRF microscopy. Shown are the averaged data (black line), the
standard deviation of the individual traces (grey halo) and the fit of the
average data to a saturating (Phase I, left panels) or decaying (Phase III,
right panels) exponential (red line). Data are shown for 125 traces from a
cell expressing wt HIV-1 (A), 89 traces from a ESCRT-recruitment
defective variant displaying diminished release (B) and 69 traces from a
maturation defective variant carrying a mutation in the PR active site
(C). As the measurements were performed with different camera
settings, the fluorescence intensities have been normalized to allow a
direct comparison between experiments.
doi:10.1371/journal.ppat.1000652.g003
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phaseIIfollowedbythedecreasein fluorescenceintensitycharacteristic
of phase III. Such fluorescence intensity curves were occasionally
observed for specific assembly sites but were in general not indicative of
the transition from phase II to phase III. In other cases, we observed an
increase in mobility of the particle (as discussed below). When the
position of a particle changes during the integration time of the camera,
the signal becomes more diffuse leading to a decrease in peak intensity.
Currently, we cannot determine what physical process or processes are,
in general, responsible for Phase III. However, the results suggest that
the onset of phase III is related to formation of late budding structures
and/or the budding event. A detailed analysis of single traces provided
a clear indication for virus release at the onset of phase III in individual
cases.
Virus release
Release of HIV-1 from the producer cell should be accompa-
nied by an increase in mobility of the virion. The particle depicted
in Figure 2A, underwent a dramatic increase in its instantaneous
velocity concomitantly with the onset of Phase III. The trajectory
of the particle, color coded for the three phases is shown in
Figure 2C and a movie of the assembly and release of the particle
is shown in the Video S4. A mean-square-displacement analysis of
the trajectory starting at Phase III shows random Brownian
motion with a 100 fold increase in the diffusion coefficient
(Figure 2D). The mobility of the particle is significantly higher
than expected for the movement of HIV-1 within the cytosol in the
absence of directed transport, although still lower than the
diffusion coefficient of HIV-1 in buffer alone [31]. The diminished
diffusion coefficient is likely due to confinement of the virus
between the cover slip and the cell.
Such clear signatures of release were rare. Due to the TIRF
geometry, we can only observe particles budding towards the
cover slip. These virions are typically constricted in the narrow
space between the cell and the cover slip or may even adhere
nonspecifically to the glass surface. In addition, released viruses
may be tethered to the plasma membrane upon release by
interaction with cell surface constituents. Complete assembly and
Figure 4. Rates of Gag assembly versus time. Assembly rates were measured at different time intervals after appearance of the first assembly
sites. (A) Average fluorescence intensity traces of clusters which appeared between 0 and 25 minutes (upper panel) and 40–60 minutes (lower panel)
after the onset of virus production on the surface of a single cell. (B) background in WF and TIRF channels (upper panel) indicating the concentration
of Gag in the cytosol and plasma membrane respectively and ratio of the fluorescent background in TIRF and WF (lower panel). The grey halo in the
lower panel shows the standard deviation of the data. (C) Rates of assembly versus time of first detection for three individual cells (left panel) and
histogram summarizing all rates from the same three cells (right panel). The black line shows a log-normal fit yielding an average rate of
(5.560.5)610
23 s
21.
doi:10.1371/journal.ppat.1000652.g004
Table 1. Kinetic rates of Gag assembly for phase I and phase III.
Gag variants Phase I (N) Rate Phase I kI (s
21) Phase III (N) Rate Phase III kIII(s
21)
WT 309 (4.360.5)610
23 49 (2.760.2)610
23
Late - 191 (5.561.8)610
23 24 (5.260.9)610
23
PR - 184 (7.961.5)610
23 47 (2.260.4)610
23
DVpu 119 (4.661.5)610
23
WT (SDCM) 60 (5.560.3)610
23 *
*Not Determined.
Kinetic rate constants were determined from data collected using TIRFM or SDCM. The errors are the standard deviation calculated from measurements on multiple cells
(4 cells for WT and PR- , 3 cells for the Late- variant and 2 cells for DVpu) and include the cell to cell variation in the rate of assembly. For measurements using SDCM, the
error represents the standard error of the exponential fit.
doi:10.1371/journal.ppat.1000652.t001
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starting from nucleation of the assembly site and using changes in
diffusional behavior or rapid disappearance of the particle as a
marker for release. Of these 18 events, 5 disappeared within the
first 60 seconds after the onset of Phase III and 8 trajectories
showed anomalies in the MSD analysis due to sticking of the virus
for a few frames to the glass cover slip and/or cell surface. Of the
remaining 5 traces, all showed random diffusional motion with a
diffusion coefficient above 10
23 mm
2/s. From these data, the
mean time from appearance of an assembly site to particle release
was determined to be 1,5006700 s. This time frame is similar to
the time of 1,3006700 s that we had previously determined as the
onset of phase III and further supports the idea that the onset of
phase III is related to the formation of late budding structures
and/or release.
To investigate whether the long delay between assembly and
release was influenced by adherence of the ventral cell surface to
the coverslip, individual HIV-1 budding events were also recorded
on the dorsal membrane using SDCM. In 12 observed events, the
average time from initiation of assembly to release was
1,70061,000 s, indistinguishable from the results obtained with
TIRFM. An example of an HIV-1 assembly/release event
recorded by SDCM is shown in Figure S6 and Video S5. Besides
these clear release events, many more viruses were found to
remain associated with the dorsal plasma membrane for extended
periods of time (at least 3 hours). This observation is consistent
with that of Larson et al. [20] and is probably a result of non-
specific sticking of newly produced virions to the cell surface.
Our data indicate that assembly of the Gag shell in HeLa cells
occurs with a characteristic time of ,200 s (or 8–9 min for 90%
completion of assembly) followed by an apparent delay of
,15 min (phase II) before the virion is released. This lag period
after formation of the Gag shell was unexpected and further
analyses are required to analyze whether release kinetics are
similar in different host cells and experimental systems. One may
speculate that the delay period serves to complete membrane
closure and fission involving host cell functions. It may also be
advantageous for the virus. For example, the time lag may allow
movement of the bud towards a virological synapse [37], which
serves as preferred pathway of virus transmission from cell to cell.
Defective virus variants
To obtain further insight into what determines the kinetics of
assembly, we performed experiments using HIV-1 variants
impaired in release due to mutation of the PTAP motif in the
p6 domain of Gag [38] or in proteolytic maturation due to a D25A
mutation in the PR active site [39]. The results are summarized in
Figure 3 and Table 1 and showed no significant differences for the
various constructs. The largest difference in the average rates of
Phase I was observed between wt and PR-defective constructs. We
compared, therefore, the distributions of rates for these two
variants. The maximum of the distribution for the PR- variant was
at (8.460.7)610
23 s
21, which compares well with the average
value of (7.961.5)610
23 s
21 from Table 1. Although these values
are higher than those obtained for wt (5.5610
23 s
21 and
4.3610
23 s
21, respectively), statistical evaluation yielded a p-
value of 0.74, indicating that the difference is not significant. We
conclude that the assembly process corresponding to Phase I is
independent of ESCRT recruitment or protease activity. PR-
defective HIV-1 had exhibited a decreased rate of release in
previous pulse-chase experiments [40], but showed no apparent
difference in the assembly phase of individual particles. To obtain
further insight, we also analyzed a variant defective in the viral
protein Vpu, which is required to counteract the tetherin-
mediated restriction to virus release in HeLa cells [28,41]. Neither
the rate of 4.6610
23 s
21 for Phase I alone (Table 1), nor the
combined duration of Phases I+II of 1,60061,000 s (Figure S5C)
appeared to be significantly different from those observed for the
wild-type virus. The average duration of the Phase II (Figure S5D),
determined as previously discussed, was calculated to be
approximately 10 min, also comparable to the wild type construct
(Figure S5B). These observations are consistent with the fact that
the tetherin-mediated restriction manifests itself after the actual
budding event.
In addition to similar assembly rates and durations of phase II,
all mutants exhibited a phase III with rates similar to that of wild
type (Table 1). Observing a similar phase III for the ESCRT-
defective variant appears counterintuitive since this variant is
known to exhibit a defect in particle release. However, a
quantitative analysis of the mobility of these particles showed
differences in the mobility as compared to the wt measurements.
The averaged diffusion coefficient determined from 170 trajecto-
ries was D=(1.561.9)?10
24 mm
2/s. In three instances, rapid
movement on the order of ,10
23 mm
2/s was observed, but these
punctae resided at the cell edge and displayed collective motion
indicating that the particles had not been released. A change in
fluorescence intensity in TIRFM without concomitant change in
instantaneous velocity can be caused by an altered axial position of
a late budding structure. Due to the exponential decay of the
evanescent wave in TIRF mode, virons or late budding structures
that are close to the coverslip would lead to an increase in the
fluorescence intensity of the assembly site observed in TIRFM but
not in WF. We exploited the sensitivity of TIRFM to the axial
position of the fluorescent protein cluster by comparing the
distributions in fluorescence intensity of the TIRF and WF
channels. A time course of the TIRF (Figure S7B) and WF (Figure
S7C) fluorescence intensity distributions at individual assembly
sites is shown in Figure S7 for three different time windows (0–
15 min, 15–30 min, 30–45 min after their initial detection). The
histogram of fluorescence intensities determined by TIRF
microscopy revealed three discernible peaks indicating different
brightness classes, one centered about 500 counts, a brighter
subpopulation at ,1,000 counts, increasing in amplitude with
time, and a third subpopulation observed as a small shoulder
around 2,000 counts. Figure S7A shows an example image
indicating individual particles from the different brightness classes.
The brighter subpopulations were hardly discernible in the WF
histograms (compare Figure S7B, D with C, E, respectively),
indicating that they represent protruding Gag clusters, i.e. trapped
virions or arrested budding structures close to the cover slip. The
late domain deficient HIV variant exhibited a second bright
subpopulation in TIRF mode, which was detectable as a shoulder
in the brightness histogram (Figure S7D, E) and is more prevalent
at the later time points. In this case, the bright fraction may
represent arrested late budding structures.
Origin of Gag molecules recruited to the budding site
In Phase I, individual Gag clusters form rapidly at the plasma
membrane and further Gag molecules are recruited to the growing
assembly sites on a time scale of minutes. To determine whether
Gag molecules arrive at the assembly site directly from the cytosol
or by lateral diffusion within the plasma membrane, we made use
of an HIV-1 variant labeled with a thermostable mutant of the
photoconvertible protein mEosFP (kindly provided by J. Wieden-
mann). This protein can undergo irreversible photoconversion
from green to red emission upon exposure to 405-nm irradiation
[42,43]. Photoconversion using TIRF excitation results in
preferential conversion of Gag.mEosFP molecules in the plasma
HIV Budding
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(Figure 5A). Ideally, when Gag is recruited exclusively from the
cytosol, the green fluorescence intensity should increase whereas
the red fluorescence intensity remains constant. In contrast,
recruitment of Gag from the surrounding membrane would result
in signal increase in the red channel, whereas the intensity in the
green channel would remain constant.
Figure 5 shows TIRF (upper panels) and WF (lower panels)
views of a cell producing HIV-1
mEos before (Figure 5B) and after
(Figure 5C) photoconversion using TIRF mode. Arrival of new
Gag molecules at the sites of virus assembly was monitored
simultaneously in the green and red channels. In the representa-
tive experiment shown here, approximately 30% of mEosFP was
photoconverted upon illumination for 90s with 405 nm light.
Illumination in TIRF mode converted primarily Gag.mEosFP
molecules at the plasma membrane and very little increase in
cytosolic background was observed in the red channel (Figure 5C,
lower right panel). As non-photoconverted Gag.mEosFP is continu-
ally recruited to the membrane, we focused our analysis on
assembly sites that appeared within 15 min after photoconversion.
Figure 5D shows the fluorescence intensity from a single assembly
site that was first observable 26 s after photoconversion. The
increase in the fluorescence intensity of the green channel was
much more pronounced than that of the red channel.
The amount of non-photoconverted Gag.mEosFP to photo-
converted Gag.mEosFP in the plasma membrane is continually
changing during the experiment. This is due to, for example,
diffusion of the labeled Gag within the plasma membrane, new
non-photoconverted Gag being delivered to the plasma mem-
brane, late maturation of the chromophore or the different
photobleaching rates for the photoconverted and non-photocon-
verted species. Therefore, we monitored the fluorescence intensity
of the plasma membrane (Figure 5E). The fluorescence intensity
after 488 nm excitation (i.e. the non-photoconverted species)
increased with time whereas the fluorescence intensity after
561 nm excitation (i.e. the photoconverted species) was gradually
decreasing. To account for the time-dependent changes in the
fluorescent signal of the non-photoconverted and photoconverted
species in the plasma membrane, we define a normalized ratio, <,
which is the ratio of the signal after 488 nm excitation to the signal
after 561 nm excitation divided by the same ratio calculated for
the background in the neighborhood of the respective assembly
site at the same time point. This normalization accounts for any
differences due to incomplete photoconversion, slow maturation of
the mEosFP chromophore, changes in the concentration of the
non-photonconverted and photoconverted Gag.mEosFP due to
diffusion within the membrane, delivery of new Gag molecules to
the plasma membrane, photobleaching, or potential Fo ¨rster
Figure 5. Recruitment of Gag to the budding site. (A) Scheme of the photoconversion experiment designed to determine the source of Gag
molecules recruited to an assembly site. Recruitment can either occur from the surrounding plasma membrane (I) or directly from the cytosol (II). By
calculating the ratio of fluorescence intensities in green and red channels at the assembly site with respect to the same ratio calculated from the local
background, the origin of the recruited Gag molecules could be determined. (B–C) Live-cell images of a HeLa cell transfected with a mixture of pCHIV
andpCHIV
mEosFP before photoconversion (B) and directly after photoconversion (C). The scale bar signifies 5 mm. (D) Intensity trajectory from an
individual Gag cluster that appeared 26 s after photoconversion. (E) The average fluorescence intensity with 488 nm excitation (green line) and with
561 nm excitation (red line) of the plasma membrane measured in the vicinity of 23 assembly sites that were detectable before photoconversion as a
function of time after photoconversion. The standard deviation of the individual traces is given as a halo. (F) The ratio of fluorescence intensity after
green excitation to the fluorescence signal after red excitation normalized to the same ratio determined from the local background measured for 102
different assembly sites in five cells.
doi:10.1371/journal.ppat.1000652.g005
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photoconverted species. In addition, the background used for the
analysis is in the near vicinity of the assembly site meaning that we
are not sensitive to undulations of the plasma membrane on the
lateral scale of ,1.5 mm or larger. However, preexisting budding
structures would have a higher percentage of photoconversion due
to the closer proximity of the virion to the cover slip than the local
background. Accordingly, this can be observed for the assembly
sites that were present before photoconversion, plotted at t=0in
Figure 5F, which show a distribution of normalized ratios with an
average value significantly lower than one. When assembly sites
recruit membrane-bound Gag molecules, the ratio of fluorescence
intensities from the individual assembly site will be approximately
equal to the background signal coming from the plasma
membrane. Technically, the background contains a contribution
of fluorescence from cytosolic non-photoconverted Gag.mEosFP
that is still observable in the TIRF evanescent field. This signal
does not appear in the fluorescence intensities of the individual
assembly sites as they are background corrected. Therefore, the
ratio of non-photoconverted signal to photoconverted signal will
be lower than that calculated for the local background:
G=R ðÞ budding sitev G=R ðÞ background when Gag is accumulated from
the plasma membrane. In the opposite case, when the majority of
Gag is recruited from the cytosol, this ratio in the assembly site
would be greater than that of the local background. Therefore, we
plotted the normalized ratio, <, and compared it to unity
(Figure 5F).
For the newly generated assembly sites, we determined this
normalized ratio either at the onset of assembly or in the time
window of 3–5 minutes after assembly has begun. Thus, we could
also investigate whether Gag is recruited from different locations
during assembly. < at the onset of nucleation was determined by
extrapolating linear fits of the early points of the fluorescence
signal and the background to the time of first detection. The
normalized ratios are plotted in Figure 5F as a function of time of
appearance after photoconversion. At early time points after
photoconversion, we observed some variability and the newly
formed assembly sites had normalized ratios both greater than and
less than one. However, after ,100 s, almost all new assembly
sites exhibited normalized ratios above one. This observation
suggests that nucleation of assembly sites involves Gag molecules
coming directly from the cytosol or Gag that has only recently
been delivered to the plasma membrane. As we cannot distinguish
between Gag molecules that were delivered directly to the
assembly site from Gag molecules that were delivered to the
plasma membrane in the direct vicinity of the assembly site and
immediately incorporated into the assembly site, it is also possible
that Gag molecules may first bind briefly to the plasma membrane
(,100s) before being incorporated into the assembly site.
Regardless of whether the Gag is delivered directly from the
cytosol to the assembly site or interacts briefly with the plasma
membrane before incorporation into the assembly site, the Gag is
effectively being delivered from the cytosol. By analyzing the
normalized ratio in the time interval of 3 to 5 minutes after
initiation of the individual sites, we determined that the assembly
sites grow with the majority of Gag coming effectively from the
cytosol (Figure S8).
Within the context of current controversial theories of HIV-1
assembly (reviewed in [15]), our results support the model that
virion formation occurs exclusively at the plasma membrane, at
least in HeLa cells. We observed no evidence for Gag containing
vesicles arriving at the plasma membrane. As a control
measurement, we performed dual-color experiments using
eGFP-GPI [44] as a membrane marker along with Gag.mCherry
(Figure 6). Interestingly, no difference in eGFP-GPI concentration
was seen at assembly sites compared to the surrounding
background (Figure 6C). This suggests that there is no preferred
incorporation or exclusion of eGFP-GPI from the budding site.
Similar results were obtained using a myristoylated and palmity-
lated version of eYFP (Figure S9 [45]). Thus, while HIV-1
particles display a ‘raft’-like lipid composition [46], the budding
sites likely represent a specialized form of DRM distinct from other
‘raft’-like membrane domains. Bright bursts of GFP fluorescence
Figure 6. Comparison of the dynamics of eGFP-GPI and HIV-1
Gag during viral assembly. (A) Live-cell images of mCherry-labeled
Gag in wide field (left panel) and TIRF (middle panel) as well as eGFP-GPI
imaged in TIRF (right panel); the scale bar represents 10 mm. (B) The
fluorescence intensity of eGFP-GPI observed in the green channel at the
location of the tracked HIV
mCherry assembly site (black line) and the
background signal in the red channel derived from a region
surrounding the tracked particle (grey line). The fluorescence intensity
from the eGFP channel is divided by a factor of 4.5. Fluctuations of the
plasma membrane in the TIRF evanescent field were detectable in both
traces, validating usage of the Gag background signal as an indicator of
membrane fluctuations in our analyses. (C) The background GPI signal
(grey) increased over time indicating the delivery of new eGFP-GPI to
the membrane. No enhancement of the eGFP-GPI signal (blue) was
found at the individual HIV budding site, whereas Gag (red) increased.
doi:10.1371/journal.ppat.1000652.g006
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most likely originate from fusion of GPI-loaded vesicles with the
plasma membrane. Such bursts were not detected in measure-
ments with Gag.eGFP. While this does not rule out that small
numbers of Gag molecules are delivered to the plasma membrane
via vesicles, the data suggest that the delivery of larger assemblies
of Gag molecules through a vesicular compartment is not involved
in the Gag assembly process. We also did not detect pre-assembled
large Gag multimers being transported to the plasma membrane
in our SDCM experiments. However, our results suggest that
HIV-1 assembly is nucleated by Gag oligo- or multimers at the
plasma membrane which are subsequently extended by further
Gag molecules recruited effectively from the cytosol with perhaps
a small contribution from Gag molecules diffusing laterally in the
plasma membrane.
Conclusions
In summary, our results indicate that formation of HIV-1
assembly sites occurs during a relatively short period after onset of
assembly in an individual cell, while particle production is
completely asynchronous in the overall culture. Virus release
occurs from individual assembly sites and not from preformed
budding platforms. Assembly of the Gag shell (phase I) occurred
with a characteristic time of ,200 s (or ,8–9 min for 90%
assembly), slightly slower than the 5–6 min recently reported by
Jouvenet et al. [22]. Using the instantaneous velocity of the
particle as a marker for extracellular release, we provide a first
estimate for the duration from appearance of an assembly site to
particle release of a complete HIV-1 particle from HeLa cells:
approximately 25 minutes. Assembly of the Gag shell appears to
constitute only a minor part of this period indicating that
traversing the membrane and fission are the rate-limiting stages
in virion formation. Similar results were obtained for release from
the ventral membrane measured via TIRF microscopy and from
the dorsal membrane determined using SDCM. Using a
photoconvertable label, we established that the Gag molecules
that participate in nucleation of a new assembly site and in bud
growth are recruited preferentially from the cytosolic pool of Gag
molecules and from recently membrane-attached Gag. We found
that, in spite of DRM-like composition of the lipid envelope, GPI
was not enriched at the budding site. The described results add
essential dynamic information to our picture of virus release and
provide an experimental basis for interfering with this stage of
virus replication.
Materials and Methods
Plasmids
Construction of plasmids pCHIV, pCHIV.eGFP, pCHIV.m-
Cherry, their late-domain defective variants, which contain a
PTAP to LIRL exchange in the p6 domain, and of the protease-
negative variants has been described elsewhere [24,25]. Variants
defective in Vpu were cloned by exchange of an EcoRI-XhoI
fragment from plasmid HIV-1 NL4-3 p210-13 39 D-Vpu [47].
pCHIV.mEOS was constructed the same way, based on a
construct encoding folding-optimized monomeric EosFP in the
pQE32 vector kindly provided by J. Wiedenmann [42,43].
Cell culture and preparation of labeled particles
HeLa and 293T cells were maintained in DMEM supplemented
with 10% FCS. For microscopic analyses, HeLa cells were
transfected using FuGene6 (Roche) according to the manufactur-
er’s instructions and imaged in phosphate buffered saline
supplemented with 0.9 mM CaCl2 and 0.5 mM MgCl2.A sa
standard for the fluorescence intensity of complete viruses,
particles were purified by ultracentrifugation from the supernatant
of 293T cells transfected by CaPO4 precipitation with a mixture of
pCHIV and pCHIV.eGFP in a molar ratio of 1:1 as previously
described [25]. The particle concentration was measured by p24
ELISA.
Single virus tracing microscope
A microscope capable of synchronous switching between TIRF-
and WF-microscopy on a frame by frame basis was built for this
study. A scheme of the experimental setup is shown in Figure S1.
The excitation paths were combined using a polarizing beam
splitter so that all wavelengths could be used for each type of
microscopy. Mechanical shutters were used to switch between
microscopy modes. In this configuration, photoconversion could
also be performed in the TIRF mode, allowing photoconversion of
plasma membrane associated Gag.mEOS molecules. The detec-
tion path was split into two channels and imaged on different
portions of an EMCCD camera (Andor Technology). For
comparison, experiments were also performed on a SDCM. A
more detailed description of the setups is given in the Supporting
Text S1.
Particle tracking algorithm
Single virus tracing was applied to track individual Gag clusters
over the time course of assembly. The tracking routine consisted
of four steps: (i) particle identification, (ii) prediction of the
particle position using a spatial-temporal filter, (iii) global
mapping of detected particles to the predicted particle position
and (iv) final assignment of particles within the movie based on
the estimates of the predicted and detected particle position. For
dual channel tracking, an additional step was incorporated to
take the union of trajectories found in each channel separately. In
addition to the position of the tracked particle, the total intensity
at the particle position was determined along with the
background about the particle, which was then subtracted from
the total intensity to provide the particle intensity. A detailed
description of the tracking algorithm can be found in the
Supporting Text S1 and in [48].
Supporting Information
Text S1 Supporting Methods
Found at: doi:10.1371/journal.ppat.1000652.s001 (0.10 MB PDF)
Figure S1 Schematic diagram of the experimental setup. The
excitation wavelength is selected with an acousto-optic tunable
filter and can be alternated frame by frame. A polarizing
beamsplitter is used to separate and combine the TIRF excitation
path and WF excitation path. The shutters were synchronized
with the camera such that alternating excitation methods could be
used with a time resolution down to 30 ms/frame.
Found at: doi:10.1371/journal.ppat.1000652.s002 (0.22 MB JPG)
Figure S2 The time course of the appearance of assembly sites.
The number of detected assembly sites on a single cell is plotted as
a function of time for a representative measurement. Starting from
the time point where the first clusters of Gag.eGFP were detected
(t=0), a large increase in the number of assembly sites was
typically seen within one hour.
Found at: doi:10.1371/journal.ppat.1000652.s003 (0.26 MB JPG)
Figure S3 Types of assembly kinetics. Three types of fluores-
cence increase were observed during virus assembly. The vast
majority of traces (,80%) followed a saturating exponential
behavior (A); in 10% to 20% of the clusters, a linear growth
HIV Budding
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that displayed an exponential growth until a plateau was reached
(C).
Found at: doi:10.1371/journal.ppat.1000652.s004 (0.29 MB JPG)
Figure S4 Assembly monitoring using SDCM. To ensure that
the rates determined from TIRFM were not influenced by the
strong dependence of the intensity of the distant of the
fluorophores from the cover slip, additional experiments were
performed using SCDM. The results of Phase I for HIV
eGFP are
shown for an individual assembly site (A) and for an average from
60 traces (B). The averaged value is shown in black along with the
standard deviation of the data in grey and an exponential fit to the
data in red.
Found at: doi:10.1371/journal.ppat.1000652.s005 (0.33 MB JPG)
Figure S5 Histogram of the duration of phase I and II for HIV
wild-type (A, B) and HIV DVpu (B,C) assembly. The time from
the first appearance of the assembly site until the onset of phase
III was determined for 160 (wt) and 69 (DVpu) individual
assembly sites respectively (A, C). The duration of phase II was
estimated as the time from 90% completion of phase I until the
onset of phase III and is plotted in panels B and D for wt and
DVpu cells respectively. A binning of 200 s was used for all of the
histograms.
Found at: doi:10.1371/journal.ppat.1000652.s006 (2.48 MB JPG)
Figure S6 Release of HIV-1 observed using SDCM. (A) An
image from Video S6 showing the assembly and release of an HI
virion monitored on the dorsal membrane of the cell using SDCM
(A). The trajectory, color coded to show the three phases, assembly
phase (phase I, red), plateau region (phase II, yellow), and release
(phase III, cyan) is overlaid. The beginning of the trajectory is
marked with an arrowhead, while the arrow is pointing to a
particle being followed. Scale bar=1 mm. The fluorescence
intensity (B) and instantaneous velocity (C) are shown for the
above trajectory with the same color coding.
Found at: doi:10.1371/journal.ppat.1000652.s007 (0.19 MB JPG)
Figure S7 Fluorescence Intensity Distribution of Individual
Assembly Sites. Image of a HeLa cell transfected with pCHIV/
pCHIV
eGFP imaged in TIRF mode (A); colored arrows indicate
individual punctae that belong to different fluorescence intensity
classes displayed in panel (B). Histograms of fluorescence
intensities normalized per frame (B) for HIV/HIV
eGFP in TIRF
mode, (C) HIV/HIV
eGFP in WF mode, (D) HIV(late-)/HIV
eYF-
P(late-) in TIRF mode and (E) HIV(late-)/HIV
eYFP(late-) in WF
mode. Histograms correspond to 0–15 (left panels), 15–30 min
(middle panels) and 30–45 min (right panels) after the start of data
collection. As measurements were performed with different
camera settings, the fluorescence intensities have been normalized
to allow a direct comparison between experiments.
Found at: doi:10.1371/journal.ppat.1000652.s008 (1.01 MB JPG)
Figure S8 Recruitment of Gag after nucleation. The ratio of
fluorescence intensity after green excitation to the fluorescence
signal after red excitation normalized to the same ratio determined
from the local background. Values are averaged over the time
interval of 3 to 5 minutes after nucleation of the budding site. The
normalized ratio is still greater than 1, indicating that the majority
of Gag being incorporated into the budding at this time is
recruited from the cytosol.
Found at: doi:10.1371/journal.ppat.1000652.s009 (0.29 MB JPG)
Figure S9 Comparison of the dynamics of MyrPalm-mYFP and
HIV-1 Gag during viral assembly. (A) Images of mCherry-labeled
Gag in wide field (left panel) and TIRF (middle panel) and MyrPalm-
eYFP in TIRF (right panel)o b t a i n e da t3 0h p t ;t h es c a l eb a r
represents 10 mm (B) Fluorescence intensities of Gag.mCherry
and MyrPalm-YFP as a function of time for an individual
budding site. No concomitant accumulation of the MyrPalm.
mYFP signal (shown in blue) with the Gag signal (show in red)
was observed.
Found at: doi:10.1371/journal.ppat.1000652.s010 (0.62 MB JPG)
Video S1 Alternating TIRFM and WF measurements of HIV
assembly and budding in a HeLa cell transfected with pCHIV and
pCHIV
eGFP. A single frame from this movie is shown in Figure 1.
Data were collected at a rate of 0.6 frames/s for a total duration of
1:57 hr:min.
Found at: doi:10.1371/journal.ppat.1000652.s011 (9.50 MB AVI)
Video S2 A potential platform budding event from a cell
transfected with pCHIV and pCHIV
eGFP. The apparently
subsequent release of three particles from a single diffraction-
limited region are shown. Data were collected at a rate of 0.16
frames/s. The duration of the movie is 30 min.
Found at: doi:10.1371/journal.ppat.1000652.s012 (0.87 MB AVI)
Video S3 A HeLa cell producing HIV.eGFP particles imaged
using a spinning-disk confocal microscope. A maximum intensity
projection over 10 z-slices with a spacing 0.3 mmb e t w e e ns l i c e s
(or a total of 3 mm) successfully eliminated the intensity
fluctuations caused by the z displacement, guaranteeing that
the measured kinetics are not influenced by axial fluctuations of
the particle in the TIRFM evanescent field. The total movie
duration is 70 min.
Found at: doi:10.1371/journal.ppat.1000652.s013 (7.48 MB AVI)
Video S4 This movie shows the budding of an individual HIV-1
virion starting from nucleation and assembly through to release.
The trajectory is color coded to show the three phases, phase I
(assembly) in red, phase II (plateau region) in yellow and phase III
(release in this case) in light blue. The movie was collected at 0.6
frames/s. The total movie duration is 45 min.
Found at: doi:10.1371/journal.ppat.1000652.s014 (3.67 MB AVI)
Video S5 The budding of a single virion from nucleation and
assembly to release measured using SDCM. The trajectory is color
coded to show the three phases, phase I (assembly) in red, phase II
(plateau region) in yellow and phase III (release in this case) in light
blue. The movie was collected at 0.06 frames/s. The total movie
duration is 55 min.
Found at: doi:10.1371/journal.ppat.1000652.s015 (1.66 MB AVI)
Video S6 The assembly of Gag clusters was investigated using
HIV
mCherry while the membrane was labeled with eGFP-GPI as a
marker for investigating fluctuations of the plasma membrane.
Alternating frames were collected in TIRFM and WF mode. A
frame from this movie is shown in Figure 6. The duration of the
movie is 56 min.
Found at: doi:10.1371/journal.ppat.1000652.s016 (2.83 MB AVI)
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